Stryker Corporation
Location
Michigan
Founded
1941-02-28
Website
Risk Signals
3740 news mentions monitored
Industry Context
This company is tracked across risk categories, including those related to its sector (e.g., Surgical and Medical Instruments and Apparatus, Orthopedic, Prosthetic, and Surgical Appliances and Supplies), including supply chain integrity, ESG practices, labor disputes, and regulatory compliance.
Filter risk signals by topic
Select a theme below to explore the company’s news mentions in specific risk areas.
Recent Articles about Stryker Corporation
Live alerts from global media, monitored by Business Radar
2025-02-13 (xtalks.com)
MedTech M&As in 2025: A Roundup -
Read our Medtech M&A 2025 roundup to learn how these strategic deals and expansions are reshaping MedTech innovation.
Read more2025-01-31 (orthoworld.com)
Stryker and Zimmer Biomet Kick Off 2025 with Strategic Moves |
Stryker divested the majority of its spinal implant business while Zimmer Biomet agreed to acquire foot-and-ankle player Paragon 28.
Read more2025-01-29 (bonezonepub.com)
Stryker, Zimmer Biomet Engage in Early 2025 M&A -
Stryker announced the divestiture of its spinal implant business to Viscogliosi Brothers, while Zimmer Biomet agreed to acquire Paragon 28.
Read more2025-01-23 (prnewswire.com)
$HAREHOLDER ALERT: The M&A Class Action Firm Encourages Stockholders of NARI, DFS, LBRDA, CCRN to Act
/PRNewswire/ -- Monteverde & Associates PC (the "M&A Class Action Firm"), has recovered millions of dollars for shareholders and is recognized as a Top 50 Firm...
Read more2025-01-21 (fabbaloo.com)
The MedTech Merger Shaping the Future: Stryker Acquires Inari Medical for $4.9 Billion «
Charles R. Goulding and Preeti Sulibhavi examine how Stryker's acquisition of Inari Medical is set to transform vascular care and accelerate advancements in 3D printing technologies for the MedTech industry.
Read more
2025-01-18 (investing.com)
Stryker launches takeover bid for Inari Medical shares at $80 each By Investing.com
Stryker launches takeover bid for Inari Medical shares at $80 each
Read more
2025-01-09 (investing.com)
Stryker shares maintain buy rating after takeover plan by .com
On Tuesday, Stryker Corporation (NYSE: ) received a reaffirmation of its Buy rating and $435.00 price target from TD Cowen as the company plans to acquire NARI for $80 per share in cash. The acquisition is seen as a strategic step for Stryker to enter the fast-growing peripheral vascular disease segment, which is expected to complement its existing portfolio.
Read more2025-01-08 (reuters.com)
Commercial Strategy News | Today's Latest Stories |
Reuters.com is your online source for the latest news stories and current events, ensuring our readers up to date with any breaking news developments
Read more2024-10-30 (marketscreener.com)
Stryker Seeks M&A
Stryker Corporation is looking for M&A. During the company?s third quarter 2024 earnings call, Mr. Kevin Lobo, Chair and Chief Executive Officer said, ?M&A environment continues to be great. Sos we...
Read more2024-10-17 (massdevice.com)
Stryker’s M&A offensive: Andy Pierce discusses some of the devicemaker’s biggest deals — and a few seen as ‘head-scratchers’
Stryker Medsurg and Neurotechnology Group President Andy Pierce explains some deals seen as "head-scratchers" when first announced.
Read more2024-10-08 (bonezonepub.com)
What’s Leading to the Slow Down in Orthopedic M&A Activity?
Stryker, Enovis and Smith+Nephew completed notable deals this year in a landscape that’s expected to remain relatively quiet into 2025.
Read more2024-10-08 (jdsupra.com)
Vertos Medical Latest Acquistion in Stryker's M&A Streak
Medical technologies giant Stryker announced on Tuesday, October 1st, that it completed the acquisition of Vertos Medical for an undisclosed amount. ...
Read more